Startup Fundraising

Indian Startups Raise ₹50 Cr in Fintech & Biotech Funding

Trackk, Cellogen Therapeutics, and Owners ID secure significant funding. Paytm launches teen payment feature. Bharti Airtel overtakes HDFC Bank in market value.

Share:
AM
Alvaro de la Maza

Partner at Aninver

Stay ahead of the market

Get instant notifications when new news matching "Financial Services & Fintech, Biotechnology & Life Sciences in India" are published.

Key Takeaways

  • Trackk raised $3.2M from Lightspeed India, Info Edge Ventures, Kotak Alts, Crucifer Investments, Mga Ventures, GSF Ventures.
  • Sector: Financial Services & Fintech, Biotechnology & Life Sciences, Consumer.
  • Geography: India.

Analysis

Indian venture capital activity saw significant momentum today, with three promising startups collectively securing approximately ₹50.3 crore. The funding infusion spans critical sectors including fintech, biotechnology, and consumer recovery technology, underscoring investor confidence in India's innovation ecosystem.

Leading the pack is Trackk, a Mumbai-based trading platform designed for younger investors. The company successfully closed an extended seed funding round, garnering ₹30 crore. This substantial investment was spearheaded by Lightspeed India, with crucial participation from Info Edge Ventures. This capital injection is earmarked for bolstering capital expenditure, expanding marketing initiatives, strengthening working capital, and general corporate needs. Notably, Trackk has also secured SEBI approval to offer brokerage services on both the NSE and BSE, positioning it for significant growth in the competitive stock trading arena.

In the vital biotechnology space, Cellogen Therapeutics has secured ₹20 crore from Kotak Alternate Asset Managers through its Kotak Life Sciences Fund I. This funding is pivotal for advancing Cellogen's innovative CAR-T pipeline, which aims to develop more accessible and effective treatments for cancers and blood disorders. The company's strategy of targeting dual antigens and its projected pricing model, significantly lower than existing therapies, presents a compelling value proposition in the high-cost cell and gene therapy market. This investment follows an earlier strategic stake acquisition by Natco Pharma.

Adding to the day's momentum, Bengaluru-based Owners ID has raised $260,000 (approximately ₹2.2 crore) in a pre-seed round. The round was led by Crucifer Investments. Owners ID is developing a unique recovery-tech solution utilizing privacy-first QR technology to create digital identities for physical assets, aiming to streamline the return of lost items. With an estimated 82 million lost-item incidents annually in India alone, the market potential for such a service is considerable.

Beyond funding news, the Indian digital payments giant Paytm has launched 'Pocket Money', a new feature enabling teenagers to conduct UPI transactions under parental supervision and within defined spending limits. This move taps into the growing market for youth-focused financial services. Meanwhile, logistics major Delhivery reported a stable Q4 profit of ₹72.4 crore, despite a robust 30% year-on-year revenue growth to ₹2,850 crore, indicating strong operational efficiency gains.

The broader Indian market also witnessed a significant corporate shift, with Bharti Airtel surpassing HDFC Bank to become the nation's second most valuable listed company, boasting a market capitalization of ₹11.78 lakh crore. This re-evaluation highlights investor confidence in Airtel's growth trajectory in the telecommunications sector, driven by subscriber expansion and increasing average revenue per user (ARPU).